October 29, 2024
TOPLINE: People diagnosed with type 2 diabetes (T2D) at age < 40 years had a high risk for incident diabetes-related complications, excess age-standardised mortality, and poorer […]
October 29, 2024
TOPLINE: Opioid use has multiple negative effects on the endocrine system and can lead to reproductive, bone, and adrenal hormone health complications, reported a scientific statement. […]
October 28, 2024
TOPLINE: Children of mothers who had obesity or eating disorders before or during pregnancy may face higher risks for neurodevelopmental and psychiatric disorders. METHODOLOGY: Researchers conducted […]
October 28, 2024
TOPLINE: Adding pembrolizumab to adjuvant chemotherapy in the first-line setting improved disease-free survival (DFS) in patients with high-risk endometrial cancer who have mismatch repair–deficient (dMMR) tumors, […]
October 28, 2024
TOPLINE: Allogeneic bone marrow–derived mesenchymal stromal cells (BM-MSCs) are safe but do not show efficacy in treating intervertebral disc degeneration (IDD) in patients with chronic low […]
October 28, 2024
TOPLINE: Atezolizumab combined with targeted therapy improved median overall survival to 19 months in patients with anaplastic thyroid carcinoma (ATC). The longest survival was observed in […]
October 28, 2024
TOPLINE: Taking screens away from toddlers an hour before bedtime resulted in slight improvements in sleep; however, this intervention did not have a significant impact on […]
October 28, 2024
TOPLINE: The extended-release fluticasone propionate injection (EP-104IAR) significantly reduces knee osteoarthritis (OA) pain over 12 weeks compared with a vehicle control, with no serious treatment-related adverse […]
October 28, 2024
TOPLINE: Stroke rates in Californians with sickle cell disease (SCD) have increased in both children and adults in the post-STOP era. The cumulative incidence of first […]